Radosław Januchowski

17PUBLICATIONS
16CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jul 15, 2026
Vismodegib Exerts a Pleotropic Effect on Topotecan-Resistant and Sensitive Ovarian Cancer Cell Lines in 2D and 3D Cell Culture Models.

|Dec 30, 2025
Elacridar Reverses P-gp-Mediated Drug Resistance in Ovarian Cancer Cells in 2D and 3D Culture Models.

Piotr Stasiak, Justyna Sopel, Julia Maria Lipowicz

|Jun 26, 2025
Elacridar Inhibits BCRP Protein Activity in 2D and 3D Cell Culture Models of Ovarian Cancer and Re-Sensitizes Cells to Cytotoxic Drugs.

Piotr Stasiak, Justyna Sopel, Artur Płóciennik

|Feb 13, 2025
The Role of Elacridar, a P-gp Inhibitor, in the Re-Sensitization of PAC-Resistant Ovarian Cancer Cell Lines to Cytotoxic Drugs in 2D and 3D Cell Culture Models.

Piotr Stasiak, Justyna Sopel, Julia Maria Lipowicz

|May 28, 2022
The Profile of MicroRNA Expression and Potential Role in the Regulation of Drug-Resistant Genes in Doxorubicin and Topotecan Resistant Ovarian Cancer Cell Lines.

Piotr Stasiak, Dominika Kaźmierczak, Karol Jopek

|Mar 25, 2022
Effect of <i>ALDH1A1</i> Gene Knockout on Drug Resistance in Paclitaxel and Topotecan Resistant Human Ovarian Cancer Cell Lines in 2D and 3D Model.

Marta Nowacka, Barbara Ginter-Matuszewska, Monika Świerczewska

Pageof 3

Frequent Collaborators

12 joint publications

Karolina Sterzyńska

7 joint publications

Monika Świerczewska

6 joint publications

Michał Nowicki

5 joint publications

Piotr Stasiak